A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160

The Molecular Signatures Database Hallmark Gene Set Collection

Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807

The cancer genome atlas pan-cancer analysis project

The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092

Modeling Survival Data: Extending the Cox Model

Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950

Defining a Cancer Dependency Map

Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276

TEAD mediates YAP-dependent gene induction and growth control

Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498

Systematic identification of genomic markers of drug sensitivity in cancer cells

Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456

The Hippo Signaling Pathway in Development and Cancer

Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,317

Hippo pathway in organ size control, tissue homeostasis, and cancer

Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206

A Landscape of Pharmacogenomic Interactions in Cancer

Iorio, F., Knijnenburg, T. A., Vis, D. J., Bignell, G. R., Menden, M. P., Schubert, M., Aben, N., Gonçalves, E., Barthorpe, S., Lightfoot, H., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.017 · Cited by 2,090

Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand

Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S., & Roth, B. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700293104 · Cited by 2,046

DrugBank 4.0: shedding new light on drug metabolism

Law, V., Knox, C., Djoumbou-Feunang, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,995

Mechanisms of Hippo pathway regulation

Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

Raamsdonk, C. D. V., Bezrookove, V., Green, G., Bauer, J. M., Gaugler, L., O’Brien, J. M., Simpson, E. M., Barsh, G. S., & Bastian, B. C. (2008) · Nature · doi:10.1038/nature07586 · Cited by 1,648

Mutations in GNA11 in Uveal Melanoma

Raamsdonk, C. D. V., Griewank, K., Crosby, M. B., Garrido, M. C., Vemula, S. S., Wiesner, T., Obenauf, A. C., Wackernagel, W., Green, G., Bouvier, N., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000584 · Cited by 1,507

G-protein-coupled receptors and cancer

Dorsam, R. T., & Gutkind, J. S. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2069 · Cited by 1,448

FAK in cancer: mechanistic findings and clinical applications

Sulzmaier, F. J., Jean, C., & Schlaepfer, D. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3792 · Cited by 1,381

The emerging roles of YAP and TAZ in cancer

Moroishi, T., Hansen, C. G., & Guan, K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3876 · Cited by 1,181

Mechanism of Blebbistatin Inhibition of Myosin II

Kovács, M., Tóth, J. S., Hetényi, C., Málnási‐Csizmadia, A., & Sellers, J. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405319200 · Cited by 1,022

Protein kinase C and other diacylglycerol effectors in cancer

Griner, E. M., & Kazanietz, M. G. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2110 · Cited by 978

Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma

Robertson, A. G., Shih, J., Yau, C. S. F., Gibb, E. A., Oba, J., Mungall, K. L., Hess, J. M., Uzunangelov, V., Walter, V., Danilova, L., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.003 · Cited by 908

An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules

Basu, A. B., Bodycombe, N. E., Cheah, J. H., Price, E. V., Liu, K., Schaefer, G. I., Ebright, R. Y., Stewart, M. L., Ito, D., Wang, S. Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.003 · Cited by 828

A gp130–Src–YAP module links inflammation to epithelial regeneration

Taniguchi, K., Wu, L.-W., Grivennikov, S. I., de Jong, P. R., Lian, I., Yu, F.-X., Wang, K., Ho, S. B., Boland, B. S., Chang, J. T., et al. (2015) · Nature · doi:10.1038/nature14228 · Cited by 633

Calcium in tumour metastasis: new roles for known actors

Prevarskaya, N. B., Skryma, R. N., & Шуба, Я. М. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3105 · Cited by 623

Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry

Feng, X., Degese, M. S., Iglesias‐Bartolomé, R., Vaque, J. P., Molinolo, A., Rodrigues, M. W., Zaidi, M. R., Ksander, B. R., Merlino, G. T., Sodhi, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.016 · Cited by 577

The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer

O’Hayre, M., Vázquez‐Prado, J., Kufareva, I., Stawiski, E. W., Handel, T. M., Seshagiri, S., & Gutkind, J. S. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3521 · Cited by 559

The Cyclic AMP PathwayPreprint

Sassone‐Corsi, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011148 · Cited by 555

Protein kinase C: poised to signal

Newton, A. C. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00477.2009 · Cited by 528

Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP

Yu, F., Luo, J., Mo, J., Liu, G., Kim, Y. C., Meng, Z., Zhao, L., Peyman, G. A., Ouyang, H., Jiang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.017 · Cited by 478

Mitogenic signaling pathways induced by G protein‐coupled receptors

Rozengurt, E. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21246 · Cited by 465

Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance

Marcotte, R., Sayad, A., Brown, K. R., Sanchez-Garcia, F., Reimand, J., Haider, M., Virtanen, C., Bradner, J. E., Bader, G. D., Mills, G. B., et al. (2016) · Cell · doi:10.1016/j.cell.2015.11.062 · Cited by 446

Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma

Carvajal, R. D., Sosman, J. A., Quevedo, J. F., Milhem, M. M., Joshua, A. M., Kudchadkar, R. R., Linette, G. P., Gajewski, T. F., Lutzky, J., Lawson, D. H., et al. (2014) · JAMA · doi:10.1001/jama.2014.6096 · Cited by 433

Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer

Cheung, H. W., Cowley, G. S., Weir, B. A., Boehm, J. S., Rusin, S., Scott, J. A., East, A., Ali, L. D., Lizotte, P. H., Wong, T. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109363108 · Cited by 423

The experimental power of FR900359 to study Gq-regulated biological processes

Schrage, R., Schmitz, A.-L., Gaffal, E., Annala, S., Kehraus, S., Wenzel, D., Büllesbach, K. M., Bald, T., Inoue, A., Shinjo, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms10156 · Cited by 383

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies

Cowley, G. S., Weir, B. A., Vázquez, F., Tamayo, P., Scott, J. A., Rusin, S. F., East-Seletsky, A., Ali, L. D., Gerath, W. F., Pantel, S. E., et al. (2014) · Scientific Data · doi:10.1038/sdata.2014.35 · Cited by 380

Use and properties of ROCK-specific inhibitor Y-27632

Narumiya, S., Ishizaki, T., & Ufhata, M. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)25449-9 · Cited by 332

Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma

Moore, A. R., Ceraudo, E., Sher, J. J., Guan, Y., Shoushtari, A. N., Chang, M. T., Zhang, J. Q., Walczak, E. G., Kazmi, M. A., Taylor, B. S., et al. (2016) · Nature Genetics · doi:10.1038/ng.3549 · Cited by 325

Essential Gene Profiles in Breast, Pancreatic, and Ovarian Cancer Cells

Marcotte, R., Brown, K. R., Suárez, F., Sayad, A., Karamboulas, K., Krzyzanowski, P. M., Sircoulomb, F., Medrano, M., Fedyshyn, Y., Koh, J. L. Y., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0224 · Cited by 303

Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes.

Gutkind, J. S., Novotny, E. A., Brann, M. R., & Robbins, K. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4703 · Cited by 291

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)

Carvajal, R. D., Piperno-Neumann, S., Kapiteijn, E., Chapman, P. B., Frank, S. J., Joshua, A. M., Piulats, J. M., Wolter, P., Cocquyt, V., Chmielowski, B., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.1090 · Cited by 272

Cell signalling diversity of the Gqα family of heterotrimeric G proteins

Hubbard, K. B., & Hepler, J. R. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.08.004 · Cited by 266

An FAK-YAP-mTOR Signaling Axis Regulates Stem Cell-Based Tissue Renewal in Mice

Hu, J. K., Du, W. T., Shelton, S. J., Oldham, M. C., DiPersio, C. M., & Klein, O. D. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.03.023 · Cited by 244

Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS

Zuidervaart, W., van Nieuwpoort, F. A., Stark, M. S., Dijkman, R., Packer, L., Borgstein, A. M., Pavey, S. J., van der Velden, P., Out, C. J., Jager, M. J., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602598 · Cited by 219

RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma

Chen, X., Wu, Q., Depeille, P., Chen, P., Thornton, S., Kalirai, H., Coupland, S. E., Roose, J. P., & Bastian, B. C. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.002 · Cited by 180

αE-catenin inhibits a Src–YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway

Li, P., Silvis, M. R., Honaker, Y., Lien, W.-H., Arron, S. T., & Vasioukhin, V. (2016) · Genes & Development · doi:10.1101/gad.274951.115 · Cited by 180

FAK controls the mechanical activation of YAP, a transcriptional regulator required for durotaxis

Lachowski, D., Cortes, E., Robinson, B., Rice, A., Rombouts, K., & Del Río Hernández, A. E. (2018) · The FASEB Journal · doi:10.1096/fj.201700721r · Cited by 175

Assembly and activation of the Hippo signalome by FAT1 tumor suppressor

Martin, D., Degese, M. S., Vitale-Cross, L., Iglesias-Bartolome, R., Valera, J. L. C., Wang, Z., Feng, X., Yeerna, H., Vadmal, V., Moroishi, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04590-1 · Cited by 174

A Genome-wide RNAi Screen Reveals a Trio-Regulated Rho GTPase Circuitry Transducing Mitogenic Signals Initiated by G Protein-Coupled Receptors

Vaque, J. P., Dorsam, R. T., Feng, X., Iglesias‐Bartolomé, R., Forsthoefel, D. J., Chen, Q., Debant, A., Seeger, M. A., Ksander, B. R., Teramoto, H., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.10.018 · Cited by 164

Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells.

Kalinec, G. M., Nazarali, A. J., Hermouet, S., Xu, N., & Gutkind, J. S. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.10.4687 · Cited by 162

Regulation of G Protein-linked Guanine Nucleotide Exchange Factors for Rho, PDZ-RhoGEF, and LARG by Tyrosine Phosphorylation

Chikumi, H., Fukuhara, S., & Gutkind, J. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108504200 · Cited by 158

Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials—TAP and VIP report no. 3

Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.059 · Cited by 145

Harnessing synthetic lethality to predict the response to cancer treatment

Lee, J. S., Das, A., Jerby‐Arnon, L., Arafeh, R., Auslander, N., Davidson, M. A., McGarry, L., James, D. T., Amzallag, A., Park, S. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04647-1 · Cited by 122

Daily shoot extension growth of peach trees growing on rootstocks that reduce scion growth is related to daily dynamics of stem water potential

Basile, B., Marsal, J., & DeJong, T. M. (2003) · Tree Physiology · doi:10.1093/treephys/23.10.695 · Cited by 111

VERTEPORFIN THERAPY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION

Groups, T. O. A.-R. M. D. W. P. T. (. A. V. I. P. T. (. S. (2004) · Retina · doi:10.1097/00006982-200402000-00001 · Cited by 94

Thrombin Protease-activated Receptor-1 Signals through Gq- and G13-initiated MAPK Cascades Regulating c-Jun Expression to Induce Cell Transformation

Marinissen, M. J., Servitja, J., Offermanns, S., Simon, M. I., & Gutkind, J. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305709200 · Cited by 93

Cross-talk between calcium and protein kinase A in the regulation of cell migration

Howe, A. K. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.05.006 · Cited by 89

Signaling by Sensory ReceptorsPreprint

Julius, D. J., & Nathans, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005991 · Cited by 85

Treatment of choroidal melanoma using photodynamic therapy

BARBAZETTO, I. A., Lee, T. C., Rollins, I. S., Chang, S., & Abramson, D. H. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)02222-5 · Cited by 85

Divergent Signaling Pathways Link Focal Adhesion Kinase to Mitogen-activated Protein Kinase Cascades

Igishi, T., Fukuhara, S., Patel, V., Katz, B., Yamada, K. M., & Gutkind, J. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30738 · Cited by 85

FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growth

Tancioni, I., Miller, N. L. G., Uryu, S. A., Lawson, C., Jean, C., Chen, X. L., Kleinschmidt, E. G., & Schlaepfer, D. D. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0551-x · Cited by 74

Identification of H-Ras, RhoA, Rac1 and Cdc42 responsive genes

Teramoto, H., Malek, R. L., Behbahani, B., Castellone, M. D., Lee, N. H., & Gutkind, J. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206364 · Cited by 54

Activation of transforming G protein-coupled receptors induces rapid tyrosine phosphorylation of cellular proteins, including p125FAK and the p130 v-src Substrate

Gutkind, J. S., & Robbins, K. C. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92363-3 · Cited by 51

Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment

Friedman, A. A., Amzallag, A., Pruteanu-Malinici, I., Baniya, S., Cooper, Z. A., Piris, A., Hargreaves, L., Igras, V., Frederick, D. T., Lawrence, D. P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140310 · Cited by 47

Reduction of hepatic ischemia/reperfusion-induced injury by a specific ROCK/Rho Kinase Inhibitor Y-27632

Ikeda, F., Terajima, H., Shimahara, Y., Kondo, T., & Yamaoka, Y. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(02)00081-1 · Cited by 26

Photodynamic therapy with verteporfin in subfoveal amelanotic choroidal melanoma (A controlled case).

Souček, P., & Cihelkova, I. (2006) · PubMed · Cited by 25

A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers

Yamaguchi, K., Iglesias‐Bartolomé, R., Wang, Z., Callejas‐Valera, J. L., Amornphimoltham, P., Molinolo, A., Cohen, E. E. W., Califano, J. A., Lippman, S. M., Luo, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7372 · Cited by 22

Oncotargeting G proteins: The Hippo in the room

Feng, X., Chen, Q., & Gutkind, J. S. (2014) · Oncotarget · doi:10.18632/oncotarget.2815 · Cited by 18

Development of a high-throughput method for the determination of ethosuximide in human plasma by liquid chromatography mass spectrometry

Bhatt, M., Shah, S. S., & Shivprakash (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.03.019 · Cited by 18

YAP as oncotarget in uveal melanoma

Yu, F., Zhang, K., & Guan, K. (2014) · Oncoscience · doi:10.18632/oncoscience.57 · Cited by 14

Uveal melanoma

Jager, M. J., Shields, C. L., Cebulla, C. M., Abdel‐Rahman, M. H., Grossniklaus, H. E., Stern, M., Carvajal, R. D., Belfort, R. N., Jia, R., Shields, J. A., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0158-0 · Cited by 857

The present and future of the Cancer Dependency Map

Arafeh, R., Shibue, T., Dempster, J. M., Hahn, W. C., & Vazquez, F. (2025) · Nature Reviews Cancer · doi:10.1038/s41568-024-00763-x · Cited by 454

Targeting FAK in anticancer combination therapies

Dawson, J. C., Serrels, A., Stupack, D. G., Schlaepfer, D. D., & Frame, M. C. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00340-6 · Cited by 407

Control of cellular responses to mechanical cues through YAP/TAZ regulation

Dasgupta, I., & McCollum, D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.007963 · Cited by 360

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer

Cunningham, R., & Hansen, C. G. (2022) · Clinical Science · doi:10.1042/cs20201474 · Cited by 355

The GNAQ-oncogenic signaling network: Targeting FAK and its synthetic lethal interactome as a precision therapeutic approach against uveal melanoma

Arang, N. (2022) · eScholarship (California Digital Library)

Abstract IA08: Regulation of YAP by tyrosine phosphorylation of core Hippo pathway components: Lessons learned from the GNAQ oncogene and FAK

Gutkind, J. S. (2020) · Molecular Cancer Research · doi:10.1158/1557-3125.hippo19-ia08

Abstract 6406: FAK and MEK co-targeting: A new multimodal precision therapy for GNAQ-driven uveal melanoma

Paradis, J. S., Acosta, M., Arang, N., Saddawi‐Konefka, R., Kishore, A., Sugase, T., Feng, X., Wood, K. C., Coma, S., Terai, M., et al. (2020) · Cancer Research · doi:10.1158/1538-7445.am2020-6406

FAK Is a Critical Mediator of GNAQ-Driven Uveal Melanoma

(2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-rw2019-024

Identifying novel molecular vulnerabilities to PTK2/FAK inhibition in G α q‐driven uveal melanoma using a kinome‐wide CRISPR/Cas9 screen

Kishore, A., Feng, X., Arang, N., Wu, X., Pachter, J. A., Schlaepfer, D. D., Tamayo, P., Cheng, Q., & Gutkind, J. S. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.647.15 · Cited by 1